Cytokinetics Receives Orphan Drug Status for ALS Treatment
Promising data from a Phase I clinical trial of CK-2017357 was announced in January.
robert l. blum
Copyright © 2025 | WordPress Theme by MH Themes
Promising data from a Phase I clinical trial of CK-2017357 was announced in January.
Copyright © 2025 | WordPress Theme by MH Themes